Managing Inflammatory Bowel Disease with Text Message Surveys
Part of Digestive system clinical trials.
This study aims to improve care and reduce health gaps for people with inflammatory bowel disease using text-message surveys to track symptoms and guide better disease management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 13 or older
- Diagnosed with inflammatory bowel disease (Crohn's, ulcerative colitis, or indeterminant colitis)
- Seen at a participating clinic within the last year
- Own or have access to a mobile phone for text messaging
- Able to read English or Spanish
- No current pouch or ostomy (surgical opening for waste)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a self-management program for people with active Crohn's disease or ulcerative colitis. It aims to improve quality of life by helping you better manage your condition.
This trial tests whether remote monitoring, using an app and home stool tests, can be a safe alternative to frequent clinic visits for people with stable IBD. If you qualify, you'll have fewer in-person appointments and more flexibility.
This study looks at how social and economic factors (like where you live and your access to care) affect medication use and quality of life for people with inflammatory bowel disease. By completing an online survey, you can help researchers understand these connections better.
This study tests a smartphone app (SEMEIA) to help monitor people with active Crohn's disease or ulcerative colitis. It may help you track your symptoms and stay in touch with your doctor without needing as many office visits.
This trial tests an app that lets you check in with your IBD care team only when you need to, instead of having regular appointments. It's for people with Crohn's disease or ulcerative colitis who are doing well and have been on the same medication for at least 3 months.
This study is developing a new questionnaire to measure self-care in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis). By participating, you will help create a tool that may improve support for patients managing their condition at home.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.